Sökning: onr:"swepub:oai:DiVA.org:umu-55519" >
Effect of lipid low...
-
Bang, Casper N.
(författare)
Effect of lipid lowering on new-onset atrial fibrillation in patients with asymptomatic aortic stenosis : The Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) study
- Artikel/kapitelEngelska2012
Förlag, utgivningsår, omfång ...
-
Elsevier,2012
-
printrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:umu-55519
-
https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-55519URI
-
https://doi.org/10.1016/j.ahj.2012.01.026DOI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Background Lipid-lowering drugs, particularly statins, have anti-inflammatory and antioxidant properties that may prevent atrial fibrillation (AF). This effect has not been investigated on new-onset AF in asymptomatic patients with aortic stenosis (AS). Methods Asymptomatic patients with mild-to-moderate AS (n = 1,421) were randomized (1: 1) to double-blind simvastatin 40 mg and ezetimibe 10 mg combination or placebo and followed up for a mean of 4.3 years. The primary end point was the time to new-onset AF adjudicated by 12-lead electrocardiogram at a core laboratory reading center. Secondary outcomes were the correlates of new-onset AF with nonfatal nonhemorrhagic stroke and a combined end point of AS-related events. Results During the course of the study, new-onset AF was detected in 85 (6%) patients (14.2/1,000 person-years of follow-up). At baseline, patients who developed AF were, compared with those remaining in sinus rhythm, older and had a higher left ventricular mass index a smaller aortic valve area index. Treatment with simvastatin and ezetimibe was not associated with less new-onset AF (odds ratio 0.89 [95% CI 0.57-1.97], P = .717). In contrast, age (hazard ratio [HR] 1.07 [95% CI 1.05-1.10], P < .001) and left ventricular mass index (HR 1.01 [95% CI 1.01-1.02], P < .001) were independent predictors of new-onset AF. The occurrence of new-onset AF was independently associated with 2-fold higher risk of AS-related outcomes (HR 1.65 [95% CI 1.02-2.66], P = .04) and 4-fold higher risk of nonfatal nonhemorrhagic stroke (HR 4.04 [95% CI 1.18-13.82], P = .03). Conclusions Simvastatin and ezetimibe were not associated with less new-onset AF. Older age and greater left ventricular mass index were independent predictors of AF development. New-onset AF was associated with a worsening of prognosis. (Am Heart J 2012;163:690-6.)
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Greve, Anders M.
(författare)
-
Boman, KurtUmeå universitet,Medicin(Swepub:umu)kubo0001
(författare)
-
Egstrup, Kenneth
(författare)
-
Gohlke-Baerwolf, Christa
(författare)
-
Kober, Lars
(författare)
-
Nienaber, Christoph A.
(författare)
-
Ray, Simon
(författare)
-
Rossebo, Anne B.
(författare)
-
Wachtell, Kristian
(författare)
-
Umeå universitetMedicin
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:American Heart Journal: Elsevier163:4, s. 690-6960002-87031097-6744
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Bang, Casper N.
-
Greve, Anders M.
-
Boman, Kurt
-
Egstrup, Kenneth
-
Gohlke-Baerwolf, ...
-
Kober, Lars
-
visa fler...
-
Nienaber, Christ ...
-
Ray, Simon
-
Rossebo, Anne B.
-
Wachtell, Kristi ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
American Heart J ...
- Av lärosätet
-
Umeå universitet